Training journal

BOND - A woman reward's her dog's good behavior with a hug.

Track your progress through the BOND™ training program. Keep this in a handy spot, like the front of your refrigerator, to provide a reminder to give your dog a daily dose of Reconcile® and as a place to make notes on your pet's progress.

BOND™ Training Journal (PDF)

Important Safety Information

  • The most common adverse reactions recorded during clinical trials with Reconcile® were calm or lethargy, reduced appetite, vomiting, shaking, diarrhea, restlessness, excessive vocalization, aggression, and, in infrequent cases, seizures.
  • Reconcile® chewable tablets are contraindicated for dogs with epilepsy or a history of seizures; with drugs that lower the seizure threshold; with a monoamine oxidase inhibitor (MAOI) or within a minimum of 14 days of discontinuing therapy with an MAOI; in dogs with a known hypersensitivity to fluoxetine HCl or other SSRIs.
  • A six week washout interval should be observed following discontinuation of therapy with Reconcile® chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine.
  • For full product label, including complete safety information, click here.

 

A dog and his owner take a quiet walk around
	the neighborhood.